Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

We need an evidence-based, randomized trial on gun control

Ryan Madanick, MD
Physician
February 25, 2013
Share
Tweet
Share

For just a moment, let’s take a scientific viewpoint about gun control here and try to leave emotions (and the Constitutional argument) out.

The best type of study to determine whether gun control and/or regulation would be a randomized trial: randomizing a state or country to regulation or not.

Since that’s not going to happen, the next best type of evidence we have to go by is observational, either case-control or cohort studies. The exposure is: gun control regulation. This could be considered dichotomously (yes/no) or continuous (level of regulation from strict to lenient/none).

The outcome is: death by guns. This could be considered in numerous ways: absolute numbers of gun deaths annually; relative numbers of gun deaths adjusting for size of population; number of gun massacres, etc. We could even consider any violent deaths, if you want to be more general.

In a case-cohort study, we’d look at the outcome first (let’s say, massacres) and look backward for the exposure, then calculate an odds ratio that the outcome was significantly associated with the exposure.

In a cohort study, we’d look at the exposure first, looking at level of gun control as a continuous variable. This could be done retrospectively or prospectively. As of now, we could only do this retrospectively. Then look for the outcomes (deaths, massacres, etc.), and determine a risk ratio that the outcome was associated with the exposure.

Either way, the data would indicate that countries with increased exposure (increasing regulation) is associated with a decreased odds/risk of the outcome (fewer deaths, massacres).

Please note that I did not say that increasing regulation caused fewer deaths, just that it was associated with fewer deaths.

Now, I do not have numerical data, so I am only going on what I understand to be true, the empirical data. If those who would not believe this to be true, the best way to deal with this is to show data that decreasing the exposure to gun regulation (i.e., increasing the populace’s ability to acquire firearms legally) is associated with fewer gun deaths.

Therefore, my preference is the following: until evidence (not raw emotions, beliefs, or Constitutional Amendments) that decreased regulation (including eliminating gun zones) results in decreased odds/risk for the outcome (gun death) is found in other countries, then there is no reason to accept the notion that we need to stop advocating for strict gun control. For that matter, stricter gun control has evidential support (even if not emotional support among some) and should be advanced.

If you choose to comment on this in the opposite direction, please think before you do. The anecdotal evidence currently being provided by those who would oppose stricter regulations is purely speculative. I am open to hearing the data to refute the above contention, but it needs to be at least as strong methodologically.

In other words, “case reports” (testimonials by individuals) or “case series” (testimonials by groups, including lobbyists) are weaker forms of evidence scientifically, and I will not consider them as valid as the comparative empirical data I have put forward as an argument.

Ryan Madanick is a gastroenterologist who blogs at Gut Check.

ADVERTISEMENT

Prev

Smoking has become hidden in the shadow of obesity

February 25, 2013 Kevin 4
…
Next

Are generic drugs as safe and effective as name brand drugs?

February 26, 2013 Kevin 11
…

Tagged as: Primary Care

Post navigation

< Previous Post
Smoking has become hidden in the shadow of obesity
Next Post >
Are generic drugs as safe and effective as name brand drugs?

ADVERTISEMENT

More by Ryan Madanick, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Medical educators: A subtle difference in wording makes a difference

    Ryan Madanick, MD
  • a desk with keyboard and ipad with the kevinmd logo

    How to get started on Twitter: A primer for doctors

    Ryan Madanick, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Billing an established patient visit as a consultation

    Ryan Madanick, MD

More in Physician

  • The overlooked power of billing in primary care

    Jerina Gani, MD, MPH
  • Why pain doctors face unfair scrutiny and harsh penalties in California

    Kayvan Haddadan, MD
  • Why physicians need a place to fall apart

    Annia Raja, PhD
  • The joy of teaching medicine through life’s toughest challenges

    John F. McGeehan, MD
  • Why health care can’t survive on no-fail missions alone

    Wendy Schofer, MD
  • The unspoken contract between doctors and patients explained

    Matthew G. Checketts, DO
  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • A new approach to South Asian heart health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Private practice employment agreements: What happens if private equity swoops in?

      Dennis Hursh, Esq | Conditions
    • Inside the final hours of a failed lung transplant

      Jonathan Friedman, RN | Conditions
    • Why South Asians in the U.S. face a silent heart disease crisis

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Why chronic pain patients and doctors are both under attack

      Richard A. Lawhern, PhD | Conditions
    • The overlooked power of billing in primary care

      Jerina Gani, MD, MPH | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 21 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • Are we repeating the statin playbook with lipoprotein(a)?

      Larry Kaskel, MD | Conditions
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Past 6 Months

    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • A physician employment agreement term that often tricks physicians

      Dennis Hursh, Esq | Finance
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
  • Recent Posts

    • A new approach to South Asian heart health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Private practice employment agreements: What happens if private equity swoops in?

      Dennis Hursh, Esq | Conditions
    • Inside the final hours of a failed lung transplant

      Jonathan Friedman, RN | Conditions
    • Why South Asians in the U.S. face a silent heart disease crisis

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Why chronic pain patients and doctors are both under attack

      Richard A. Lawhern, PhD | Conditions
    • The overlooked power of billing in primary care

      Jerina Gani, MD, MPH | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

We need an evidence-based, randomized trial on gun control
21 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...